Science news articles about 'exenatide'

... study medication. There was no statistically significant difference in beginning weight between the exenatide-treated subjects and the control subjects, who got the placebo injection. Individuals who ...

In combination with diet and exercise, the diabetes drug exenatide helped nondiabetic, obese individuals lose over three times more weight than those receiving a placebo, or dummy treatment, for 6 ...

... -- a combination of etanercept (an anti-inflammatory drug developed to treat rheumatoid arthritis) and exenatide (a drug approved for use in type 2 diabetes to improve glucose control) -- and the ...

... 14 injections a week, as in the currently available version of the drug known as Exenatide (Byetta). In an international multicentre 6-month clinical trial involving 300 eligible patients, 75 per ...

... justifies its price. New drugs such as sitagliptin (brand name Januvia, $160 per prescription) and exenatide (Byetta, $210) cost eight to 11 times more than older, generic drugs such as metformin or ...

... Biotechnology company Amylin Pharmaceuticals Inc. said Tuesday it asked the Food and Drug Administration to approve its highly anticipated once-weekly injectable diabetes treatment exenatide LAR....

... , there is a lack of comparator trials with newer glucose-lowering agents such as, for example, exenatides or gliptins. No trials were found even for well-established antidiabetics such as insulin or ...